Filter
1186
Filtered Results: 1186
Text search:
serology
Featured
Recommendations
151
New Publications
309
Language
Document type
No document type
576
Guidelines
307
Studies & Reports
149
Manuals
62
Fact sheets
34
Strategic & Response Plan
31
Situation Updates
10
Training Material
8
Infographics
6
Brochures
2
Resource Platforms
1
Countries / Regions
India
55
Global
45
Germany
36
Latin America and the Carribbean
29
Paraguay
28
South Africa
27
Nigeria
26
Colombia
22
Western and Central Europe
22
Argentina
22
Ethiopia
19
Philippines
18
Bangladesh
17
Kenya
16
Tanzania
15
Venezuela
14
Africa
13
Nepal
12
Sierra Leone
12
Zambia
12
Mozambique
11
Rwanda
10
Malawi
10
West and Central Africa
10
Bolivia
10
Brazil
10
Indonesia
10
Ghana
8
Congo, Democratic Republic of
8
East and Southern Africa
8
Uganda
8
Eastern Europe
8
Russia
8
Liberia
7
Lesotho
6
Peru
6
Ukraine
5
Senegal
5
Asia
5
Middle East and North Africa
5
Namibia
5
Angola
5
Myanmar / Burma
5
Pakistan
5
Syria
4
Burkina Faso
4
South–East Asia Region
4
Spain
4
China
3
Cameroon
3
Afghanistan
3
Zimbabwe
3
USA
3
Haiti
3
Cambodia
3
Eastern Europe and Central Asia
3
France
3
Vietnam
3
Central African Republic
3
South Sudan
3
Ecuador
3
North Macedonia
2
Mexico
2
El Salvador
2
Turkey
2
Benin
2
Iran
2
Albania
2
Guinea
2
Jordan
2
Saudi Arabia
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Sudan
2
Chad
2
Botswana
2
Iraq
2
Eswatini/ Swaziland
2
Tajikistan
1
Australia
1
Togo
1
Chile
1
Laos
1
Morocco
1
Qatar
1
Italy
1
Guinea-Bissau
1
Western Pacific Region
1
North America
1
Uruguay
1
Tunisia
1
United Kingdom
1
Southern Africa
1
Papua New Guinea
1
Sri Lanka
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Mali
1
Libya
1
Bhutan
1
Somalia
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
470
Clinical Guidelines
174
Pharmacy & Technologies
48
Public Health
36
Key Resources
23
Women & Child Health
21
Capacity Building
6
Toolboxes
NTDs
170
COVID-19
163
HIV
121
Rapid Response
97
TB
63
Zika
57
Ebola & Marburg
27
Refugee
26
AMR
18
Mental Health
16
Pharmacy
15
Planetary Health
13
Caregiver
11
Polio
8
Cholera
6
Natural Hazards
5
NCDs
4
Conflict
3
Global Health Education
2
Disability
1
Health Financing Toolbox
1
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Hendra virus (HeV) continues to pose a serious public health concern as spillover events occur sporadically. Terminally ill horses can exhibit a range of clinical signs including frothy nasal discharge, ataxia or forebrain signs. Early signs, if detected, can include depression, inappetence, colic o...
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
WHO/CDS/CSR/EDC/99.2 Plague Manual
Epidemiology, Distribution, Surveillance and Control
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical man...
Investigación original / Original research
Rev Panam Salud Publica 35(1), 2014
Document d’information scientifique
24 avril 2020
Le développement d’une immunité face à un agent pathogène à la suite d’une infection naturelle comporte plusieurs étapes et prend généralement une à deux semaines. Une infection virale entraîne immédiatement une réponse immunit...
Обновленная версия. В этой версии приведены обновленные рекомендации относительно стратегии диагностического тестирования в контексте обновлённой классификаци...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV).
To provide supply & equipment to collect, test and transfuse 50 blood bags.
The new Collection testing and transfusion kit 2021 is specially designed for emergency settings where blood transfusion is crucial. It contains all the necessary supply & equipment needed to collect blood, test it agains...
The Nigeria Centre for Disease Control (NCDC) declared a Yellow Fever (YF) outbreak and activated a multi-sectoral Emergency Operations Centre for coordination of Yellow Fever response on 12 November 2020. The outbreak, which mainly affected three states of Delta, Enugu and Bauchi, already recorded ...
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te...
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...
It is recommended that egg based quadrivalent vaccines for use in the 2019-2020 northern hemisphere influenza season contain the following:
an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
an A(H3N2) virus to be announced on 21 March 2019*;
a B/Colorado/06/2017-like virus (B/Victoria/...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
